Propranolol, a nonselective beta-blocker, was administered to a client with paruresis (psychogenic urinary retention) following a novel in vivo exposure treatment. The client did not report a significant increase in his ability to urinate in public facilities during subsequent exposures. Rationale for including propranolol as an adjunct to exposure therapy of paruresis is discussed.
Get full access to this article
View all access options for this article.
References
1.
BarlowD. H. (1988) Anxiety and its disordersNew York: Guilford.
2.
ReesB.LeachD. (1975) The social inhibition of micturition (paruresis): Sex similarities and differencesJournal of the American College Health Association, 23, 203–205.
3.
ZgouridesG. D. (1987) Paruresis: Overview and implications for treatmentPsychological Reports, 60, 1171–1176.
4.
ZgouridesG. D. (1988) Bethanechol chloride as a suggested adjunct to prolonged in vivo exposure therapy in the treatment of paruresisPerceptual and Motor Skills, 66, 319–322.
5.
ZgouridesG.WarrenR.EnglertM. (1990) Use of a portable radio-headset as an adjunct to exposure therapy in treating paruresisPhobia Practice and Research Journal, 3, 43–44.
